Skip to main content

Table 2 Description of inpatients with a FGM/C (n = 207) as primary or secondary diagnosis between 2016 and 2018 followed in one of four Swiss university hospitals (Geneva, Lausanne, Bern and Zürich)

From: Diagnoses and procedures of inpatients with female genital mutilation/cutting in Swiss University Hospitals: a cross-sectional study

Variables

2016 (n = 42)

2017 (n = 69)

2018 (n = 96)

Center, n (%)

   

 Geneva

20 (47.6)

24 (34.8)

67 (69.8)

 Lausanne

13 (31.0)

10 (14.5)

19 (19.8)

 Bern

3 (7.1)

23 (33.3)

6 (6.3)

 Zürich

6 (14.3)

12 (17.4)

4 (4.2)

Country of origin, n (%)

   

 Benin

0 (0)

0 (0)

1 (1.0)

 Burkina Faso

1 (2.4)

2 (2.9)

0 (0)

 Cameroon

1 (2.4)

0 (0)

0 (0)

 Côte d’Ivoire

1 (2.4)

1 (1.5)

1 (1.0)

 Egypt

0 (0)

0 (0)

5 (5.2)

 Eritrea

12 (28.6)

37 (53.6)

36 (37.5)

 Ethiopia

2 (4.8)

3 (4.4)

2 (2.1)

 Guinea

0 (0)

0 (0)

6 (6.2)

 Guinea-Bissau

0 (0)

0 (0)

2 (2.1)

 Mali

0 (0)

0 (0)

1 (1.0)

 Mauritania

0 (0)

0 (0)

1 (1.0)

 Nigeria

1 (2.4)

1 (1.5)

3 (3.1)

 Senegal

0 (0)

0 (0)

3 (3.1)

 Somalia

14 (33.3)

18 (26.1)

22 (22.9)

 Sudan and South Sudan

1 (2.4)

1 (1.5)

3 (3.1)

 Unknown or other

9 (21.4)

6 (8.7)

10 (10.4)

Service, n (%)

   

 Gynaecology

13 (31.0)

12 (17.4)

9 (9.4)

 Gynaecology or obstetricsa

1 (2.4)

23 (33.3)

6 (6.3)

 Obstetrics

23 (54.8)

33 (47.8)

79 (82.3)

 Others

5 (11.9)

1 (1.5)

2 (2.1)

Mean age at first visit (± SD, median)

30.7 (± 12.0, 27)

27.7 (± 6.1, 27.4)

29.8 (± 6.7, 30)

FGM/C type, n (%)

   

 Type I

3 (7.1)

13 (18.8)

10 (10.4)

 Type II

8 (19.1)

16 (23.2)

33 (34.4)

 Type III

21 (50.0)

33 (47.8)

39 (40.6)

 Type IV

0 (0)

1 (1.5)

2 (2.1)

 Unspecified or other

10 (23.8)

6 (8.7)

12 (12.5)

  1. aData obtained from Bern did not specify whether patients were admitted in gynecology or obstetrics